CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells.
SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)是一种单次跨膜受体,旨在特异性识别并清除癌细胞。CAR对B细胞恶性肿瘤疗效显著,但促成CAR-T 细胞活性的细胞内信号事件仍未完全阐明。为进一步了解CAR-T 细胞信号传导以及CAR靶细胞可能产生的信号应答,研究者将第三代CD19-CAR-T 细胞与SILAC标记的Raji B细胞共培养,采用两种不同的磷酸肽富集策略捕获磷酸肽,并通过液相色谱-串联质谱(LC-MS/MS)进行分析。结果显示,CD19-CAR-T 细胞中若干关键磷酸化事件上调,这些事件也见于经典T细胞受体(TCR)信号通路;共培养后,Raji B细胞中与B细胞受体信号相关的磷酸化事件则显著减少。数据提示,CD19-CAR刺激同时激活了若干CD19-CAR特异性信号通路和经典TCR信号;与CD19-CAR-T 细胞接触后,Raji B细胞的整体磷酸化水平降低。
Chimeric antigen receptor (CAR) is a single-pass transmembrane receptor designed to specifically target and eliminate cancers. While CARs prove highly efficacious against B cell malignancies, the intracellular signaling events which promote CAR T cell activity remain elusive.
To gain further insight into both CAR T cell signaling and the potential signaling response of cells targeted by CAR, we analyzed phosphopeptides captured by two separate phosphoenrichment strategies from third generation CD19-CAR T cells cocultured with SILAC labeled Raji B cells by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Here, we report that CD19-CAR T cells upregulated several key phosphorylation events also observed in canonical T cell receptor (TCR) signaling, while Raji B cells exhibited a significant decrease in B cell receptor-signaling related phosphorylation events in response to coculture.
Our data suggest that CD19-CAR stimulation activates a mixture of unique CD19-CAR-specific signaling pathways and canonical TCR signaling, while global phosphorylation in Raji B cells is reduced after association with the CD19-CAR T cells.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。